BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19535990)

  • 1. Lewy body pathology in normal elderly subjects.
    Markesbery WR; Jicha GA; Liu H; Schmitt FA
    J Neuropathol Exp Neurol; 2009 Jul; 68(7):816-22. PubMed ID: 19535990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases.
    Fujishiro H; Ferman TJ; Boeve BF; Smith GE; Graff-Radford NR; Uitti RJ; Wszolek ZK; Knopman DS; Petersen RC; Parisi JE; Dickson DW
    J Neuropathol Exp Neurol; 2008 Jul; 67(7):649-56. PubMed ID: 18596548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathology of cognitively normal elderly.
    Knopman DS; Parisi JE; Salviati A; Floriach-Robert M; Boeve BF; Ivnik RJ; Smith GE; Dickson DW; Johnson KA; Petersen LE; McDonald WC; Braak H; Petersen RC
    J Neuropathol Exp Neurol; 2003 Nov; 62(11):1087-95. PubMed ID: 14656067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
    Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
    Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response.
    Apaydin H; Ahlskog JE; Parisi JE; Boeve BF; Dickson DW
    Arch Neurol; 2002 Jan; 59(1):102-12. PubMed ID: 11790237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
    Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
    Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lewy body variant of Alzheimer's disease or cerebral type lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem.
    Yokota O; Tsuchiya K; Uchihara T; Ujike H; Terada S; Takahashi M; Kimura Y; Ishizu H; Akiyama H; Kuroda S
    Neuropathology; 2007 Feb; 27(1):21-35. PubMed ID: 17319280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies.
    Ballard CG; Jacoby R; Del Ser T; Khan MN; Munoz DG; Holmes C; Nagy Z; Perry EK; Joachim C; Jaros E; O'Brien JT; Perry RH; McKeith IG
    Am J Psychiatry; 2004 May; 161(5):843-9. PubMed ID: 15121649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinico-Neuropathological Findings in the Oldest Old from the Georgia Centenarian Study.
    Tanprasertsuk J; Johnson EJ; Johnson MA; Poon LW; Nelson PT; Davey A; Martin P; Barbey AK; Barger K; Wang XD; Scott TM
    J Alzheimers Dis; 2019; 70(1):35-49. PubMed ID: 31177211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration.
    Chai YL; Chong JR; Weng J; Howlett D; Halsey A; Lee JH; Attems J; Aarsland D; Francis PT; Chen CP; Lai MKP
    Brain Pathol; 2019 Jan; 29(1):63-74. PubMed ID: 30051532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lewy body-related alpha-synucleinopathy in aging.
    Saito Y; Ruberu NN; Sawabe M; Arai T; Kazama H; Hosoi T; Yamanouchi H; Murayama S
    J Neuropathol Exp Neurol; 2004 Jul; 63(7):742-9. PubMed ID: 15290899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinician-judged hearing impairment and associations with neuropathologic burden.
    Brenowitz WD; Besser LM; Kukull WA; Keene CD; Glymour MM; Yaffe K
    Neurology; 2020 Sep; 95(12):e1640-e1649. PubMed ID: 32759190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations.
    Jacobson SA; Morshed T; Dugger BN; Beach TG; Hentz JG; Adler CH; Shill HA; Sabbagh MN; Belden CM; Sue LI; Caviness JN; Hu C;
    Parkinsonism Relat Disord; 2014 Sep; 20(9):1009-14. PubMed ID: 25027359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies.
    Schneider JA; Arvanitakis Z; Yu L; Boyle PA; Leurgans SE; Bennett DA
    Brain; 2012 Oct; 135(Pt 10):3005-14. PubMed ID: 23065790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
    Fujishiro H; Iseki E; Higashi S; Kasanuki K; Murayama N; Togo T; Katsuse O; Uchikado H; Aoki N; Kosaka K; Arai H; Sato K
    Neurosci Lett; 2010 Dec; 486(1):19-23. PubMed ID: 20851165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive burden and excess Lewy-body pathology in the Lewy-body variant of Alzheimer disease.
    Serby M; Brickman AM; Haroutunian V; Purohit DP; Marin D; Lantz M; Mohs RC; Davis KL
    Am J Geriatr Psychiatry; 2003; 11(3):371-4. PubMed ID: 12724118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional Overlap of Pathologies in Lewy Body Disorders.
    Colom-Cadena M; Grau-Rivera O; Planellas L; Cerquera C; Morenas E; Helgueta S; Muñoz L; Kulisevsky J; Martí MJ; Tolosa E; Clarimon J; Lleó A; Gelpi E
    J Neuropathol Exp Neurol; 2017 Mar; 76(3):216-224. PubMed ID: 28395086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC).
    Yokota O; Terada S; Ishizu H; Tsuchiya K; Kitamura Y; Ikeda K; Uéda K; Kuroda S
    Acta Neuropathol; 2002 Oct; 104(4):333-41. PubMed ID: 12200618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.